Approach to risk stratification of atherosclerotic cardiovascular disease
Source : https://www.cfp.ca/content/68/9/654
Objective To outline the 2021 Canadian Cardiovascular Society (CCS) dyslipidemia guidelines and to present the current approaches to cardiovascular risk stratification, including the incorporation of biomarkers and imaging tests. Sources of information Current guidelines were reviewed and an Ovid MEDLINE literature search was performed.
Conclusions: Biomarkers and imaging tests have the potential to improve ASCVD risk stratification by reclassifying any patient whose risk has been inaccurately estimated by traditional methods. Recently published guidelines by the CCS suggest the use of biomarkers and imaging in certain patient groups.